Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 2, Pages 313
Publisher
MDPI AG
Online
2021-01-18
DOI
10.3390/cancers13020313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer
- (2020) Ye Lu et al. JOURNAL OF MEDICAL GENETICS
- ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium
- (2020) Justine Münsterberg et al. NEURO-ONCOLOGY
- Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab
- (2020) Justine Bellier et al. Cell Reports
- Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma
- (2020) Katherine Minjee Chung et al. CELL
- Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
- (2020) Esther Molina-Montes et al. GUT
- An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases
- (2020) Philip J. Broadhurst et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
- (2020) Bao Quoc Lam et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice
- (2020) Stefano Menini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Association between Metformin Use and Clinical Outcomes Following Pancreaticoduodenectomy in Patients with Type 2 Diabetes and Pancreatic Ductal Adenocarcinoma
- (2020) Daegwang Yoo et al. Journal of Clinical Medicine
- Effect of Metabolic Health and Obesity Phenotype on the Risk of Pancreatic Cancer: A Nationwide Population-Based Cohort Study
- (2020) Hye Soo Chung et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin and pancreatic cancer survival: Real effect or immortal time bias?
- (2019) Min Wei et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Advanced Glycation End-products in Carcinogenesis and their Therapeutic Implications
- (2019) David Schröter et al. CURRENT PHARMACEUTICAL DESIGN
- High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells
- (2019) Chun-Mei Hu et al. Cell Metabolism
- Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
- (2019) Dan Wang et al. Cell Communication and Signaling
- The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging
- (2019) Thibault Teissier et al. BIOGERONTOLOGY
- Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
- (2019) María Teresa Blasco et al. CANCER CELL
- The Impact of Serum Glucose in the Treatment of Locoregionally Advanced Pancreatic Cancer
- (2019) Nick A. Iarrobino et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma
- (2019) Anne Wynn et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- In Vitro Anticancer Activities of B6 Vitamers: A Mini-review
- (2019) TAISUKE MATSUO et al. ANTICANCER RESEARCH
- L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes
- (2019) Stefano Menini et al. CURRENT MEDICINAL CHEMISTRY
- Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer–Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study
- (2019) Jaelim Cho et al. DIABETES CARE
- Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
- (2019) Yongde Luo et al. GASTROENTEROLOGY
- The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study
- (2019) Dong-Hoe Koo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
- (2019) Yan Li et al. Cancer Management and Research
- Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality
- (2019) Ramteke et al. Cancers
- Glucose Metabolism in Pancreatic Cancer
- (2019) Liang Yan et al. Cancers
- Differential contribution of possible pattern‐recognition receptors to advanced glycation end product–induced cellular responses in macrophage‐like RAW264.7 cells
- (2019) Masahiro Watanabe et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus
- (2019) Adetunji T. Toriola et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer
- (2019) Thomas Hank et al. PANCREATOLOGY
- The intricate relationship between diabetes, obesity and pancreatic cancer
- (2019) Silvano Paternoster et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?
- (2018) Marco Gallo et al. CANCER TREATMENT REVIEWS
- Carnosine Catalyzes the Formation of the Oligo/Polymeric Products of Methylglyoxal
- (2018) Tim Weigand et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis
- (2018) Ayush Sharma et al. GASTROENTEROLOGY
- The advanced glycation end-product N ϵ -carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention
- (2018) Stefano Menini et al. JOURNAL OF PATHOLOGY
- Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort
- (2018) Veronica Wendy Setiawan et al. JNCI-Journal of the National Cancer Institute
- Do all roads lead to the Rome? The glycation perspective!
- (2018) Saheem Ahmad et al. SEMINARS IN CANCER BIOLOGY
- AGEs, RAGEs and s-RAGE; friend or foe for cancer
- (2018) Saheem Ahmad et al. SEMINARS IN CANCER BIOLOGY
- Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model
- (2018) Hui-Hua Chang et al. Scientific Reports
- The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
- (2018) Da Young Lee et al. Scientific Reports
- Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
- (2018) Thibault Fiolet et al. BMJ-British Medical Journal
- Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
- (2018) Thibault Fiolet et al. BMJ-British Medical Journal
- Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort
- (2018) Veronica Wendy Setiawan et al. JNCI-Journal of the National Cancer Institute
- A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women
- (2018) Donna L. White et al. Cancer Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global trends in diabetes complications: a review of current evidence
- (2018) Jessica L. Harding et al. DIABETOLOGIA
- Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
- (2018) Estifanos Baye et al. Nutrients
- Is “Preparation for Oxidative Stress” a Case of Physiological Conditioning Hormesis?
- (2018) Marcus F. Oliveira et al. Frontiers in Physiology
- Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study
- (2018) Weiheng Wen et al. Diabetes Therapy
- A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
- (2018) R. Dankner et al. Cancer Epidemiology
- Therapeutic potential of carbonyl-scavenging carnosine derivative in metabolic disorders
- (2018) Jacob M. Haus et al. JOURNAL OF CLINICAL INVESTIGATION
- A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress
- (2018) Ethan J. Anderson et al. JOURNAL OF CLINICAL INVESTIGATION
- Obesity and cancer risk: Emerging biological mechanisms and perspectives
- (2018) Konstantinos I. Avgerinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
- (2018) Marco Mol et al. Redox Biology
- Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies
- (2017) Yuanjie Pang et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC)
- (2017) Marcus Hollenbach INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study
- (2017) Robert Carreras-Torres et al. JNCI-Journal of the National Cancer Institute
- Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma
- (2017) Vicente Morales-Oyarvide et al. PANCREATOLOGY
- The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study
- (2017) Robert Carreras-Torres et al. JNCI-Journal of the National Cancer Institute
- Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice
- (2017) Hui-Hua Chang et al. PLoS One
- Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice
- (2017) Thomas Albrecht et al. Scientific Reports
- Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death
- (2017) Marie-Julie Nokin et al. Scientific Reports
- Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
- (2016) Mingzhan Xue et al. DIABETES
- Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
- (2016) Bendix Carstensen et al. DIABETOLOGIA
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
- (2016) Ralph Gruber et al. GASTROENTEROLOGY
- Robust Early Inflammation of the Peripancreatic Visceral Adipose Tissue During Diet-Induced Obesity in the KrasG12D Model of Pancreatic Cancer
- (2016) Kathleen M. Hertzer et al. PANCREAS
- Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients
- (2016) Erica Dugnani et al. PANCREATOLOGY
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
- (2016) J. Incio et al. Cancer Discovery
- Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis
- (2016) Marie-Julie Nokin et al. eLife
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect
- (2016) Luca Regazzoni et al. Scientific Reports
- Intrinsic carnosine metabolism in the human kidney
- (2015) Verena Peters et al. AMINO ACIDS
- New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications and risk of pancreatic cancer
- (2015) Yunxia Lu et al. BRITISH JOURNAL OF CANCER
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
- (2015) Andy Menke et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis
- (2015) Shanshan Song et al. PLoS One
- Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes
- (2015) Barbara Chiavarina et al. Oncotarget
- Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients
- (2014) Gianpaolo Balzano et al. ACTA DIABETOLOGICA
- Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study
- (2014) Li Jiao et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium
- (2014) C. Bosetti et al. ANNALS OF ONCOLOGY
- Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
- (2014) Pikli Batabyal et al. ANNALS OF SURGICAL ONCOLOGY
- Ratio of Serum Levels of AGEs to Soluble Form of RAGE Is a Predictor of Endothelial Function
- (2014) Masato Kajikawa et al. DIABETES CARE
- Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
- (2014) Jessica L. Harding et al. DIABETES CARE
- Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice
- (2014) Stefano Menini et al. DIABETOLOGIA
- Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
- (2014) W. Zhang et al. Science Signaling
- RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
- (2014) R Kang et al. Cell Death & Disease
- Role of advanced glycation end products in cellular signaling
- (2014) Christiane Ott et al. Redox Biology
- The glyoxalase pathway: the first hundred years… and beyond
- (2013) Marta Sousa Silva et al. BIOCHEMICAL JOURNAL
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
- (2013) Krushna C. Patra et al. CANCER CELL
- Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
- (2013) Christian Rask-Madsen et al. Cell Metabolism
- The Critical Role of Methylglyoxal and Glyoxalase 1 in Diabetic Nephropathy
- (2013) N. Rabbani et al. DIABETES
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice
- (2013) Bincy Philip et al. GASTROENTEROLOGY
- Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice
- (2013) Tobias Pusterla et al. HEPATOLOGY
- CD166/ALCAM Mediates Proinflammatory Effects of S100B in Delayed Type Hypersensitivity
- (2013) R. von Bauer et al. JOURNAL OF IMMUNOLOGY
- Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer
- (2013) Brian M. Wolpin et al. JNCI-Journal of the National Cancer Institute
- New insights into pancreatic cancer-induced paraneoplastic diabetes
- (2013) Raghuwansh P. Sah et al. Nature Reviews Gastroenterology & Hepatology
- The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
- (2013) R Kang et al. ONCOGENE
- Unlocking the biology of RAGE in diabetic microvascular complications
- (2013) Michaele B. Manigrasso et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pancreatic cancer: why is it so hard to treat?
- (2013) Paul E. Oberstein et al. Therapeutic Advances in Gastroenterology
- Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs
- (2012) Giulio Vistoli et al. AMINO ACIDS
- AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway
- (2012) Rui Kang et al. Autophagy
- D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation
- (2012) Stefano Menini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
- (2012) Joanne W. Elena et al. CANCER CAUSES & CONTROL
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
- (2012) Carolina Navas et al. CANCER CELL
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
- (2012) T. Arumugam et al. CLINICAL CANCER RESEARCH
- Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
- (2012) Mitsuro Kanda et al. GASTROENTEROLOGY
- The Receptor for Advanced Glycation End Products Promotes Pancreatic Carcinogenesis and Accumulation of Myeloid-Derived Suppressor Cells
- (2012) P. J. Vernon et al. JOURNAL OF IMMUNOLOGY
- The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia
- (2012) R. Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A multicellular signal transduction network of AGE/RAGE signaling
- (2012) Sowmya Soman et al. Journal of Cell Communication and Signaling
- Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studies
- (2011) D. Aune et al. ANNALS OF ONCOLOGY
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- Heat-shock protein 27 (Hsp27) as a target of methylglyoxal in gastrointestinal cancer
- (2011) Tomoko Oya-Ito et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study
- (2011) L. Jiao et al. CANCER RESEARCH
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
- (2011) Qiwen Ben et al. EUROPEAN JOURNAL OF CANCER
- Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes
- (2011) Lian Engelen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study
- (2011) Kevin Y. Urayama et al. INTERNATIONAL JOURNAL OF CANCER
- Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma
- (2011) Liguo Lin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Type 2 Diabetes Mellitus: A Possible Surgically Reversible Intestinal Dysfunction
- (2011) Priscila C. Sala et al. OBESITY SURGERY
- Diabetes and Pancreatic Cancer
- (2011) J. Trent Magruder et al. PANCREAS
- The hormesis database: The occurrence of hormetic dose responses in the toxicological literature
- (2011) Edward J. Calabrese et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Past Medical History and Pancreatic Cancer Risk: Results From a Multicenter Case-Control Study
- (2010) Patrick Maisonneuve et al. ANNALS OF EPIDEMIOLOGY
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- The Receptor for Advanced Glycation End-Products (RAGE) Protects Pancreatic Tumor Cells Against Oxidative Injury
- (2010) Rui Kang et al. ANTIOXIDANTS & REDOX SIGNALING
- Diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies
- (2010) Donghui Li et al. CANCER CAUSES & CONTROL
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden
- (2010) X. Shu et al. DIABETIC MEDICINE
- A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus
- (2010) A. Alkhalaf et al. DIABETOLOGIA
- Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1)
- (2010) Jakub Drozak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats
- (2010) Olaf Brouwers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
- (2010) Giancarlo Aldini et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
- (2009) C Kahlert et al. BRITISH JOURNAL OF CANCER
- Glycemic Index, Carbohydrates, Glycemic Load, and the Risk of Pancreatic Cancer in a Prospective Cohort Study
- (2009) L. Jiao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The receptor RAGE: Bridging inflammation and cancer
- (2009) Astrid Riehl et al. Cell Communication and Signaling
- The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
- (2009) R Kang et al. CELL DEATH AND DIFFERENTIATION
- Hormesis and medicine
- (2008) Edward J. Calabrese BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
- (2008) Rahul Pannala et al. GASTROENTEROLOGY
- RAGE signaling sustains inflammation and promotes tumor development
- (2008) Christoffer Gebhardt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers
- (2008) S. Yamagishi et al. MEDICAL HYPOTHESES
- Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors
- (2007) A Negre-Salvayre et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More